Smartphone app shows improvements in anxiety for people with pulmonary fibrosis

Patients with pulmonary fibrosis who used a smartphone app that offers cognitive behavioral therapy showed improvements in anxiety levels and quality of life, according to a press release.
Almee was developed by Alex Therapeutics and Vicore Pharma to provide 9 weeks of CBT for the treatment of anxiety for people with pulmonary fibrosis, according to the release from Alex Therapeutics.
To test the effectiveness of Almee, the companies conducted a randomized controlled parallel-group clinical study with 108 participants. Results were quantified with GAD-7 anxiety scores and King’s Brief

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.